Algifor Dolo Rhinogrippal 200 mg / 30 mg
Algifor Dolo Rhinogrippal 200 mg / 30 mg is a medicine authorised by Swissmedic under authorisation number 68264. The authorisation holder is Verfora SA. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 21 January 2022 and the authorisation is valid without a time limit. ATC code M01AE51 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 68264 |
|---|---|
| Name | Algifor Dolo Rhinogrippal 200 mg / 30 mg |
| Full name | Algifor Dolo Rhinogrippal 200 mg / 30 mg, gélules |
| Authorisation holder | Verfora SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | M01AE51 |
| First authorisation | 21 January 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Algifor Dolo Rhinogrippal 200 mg / 30 mg, gélules | D | 21 January 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Kapsel(n) | M01AE51 | 07.10.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Algifor Dolo Rhinogrippal 200 mg / 30 mg authorised in Switzerland?
Yes. Algifor Dolo Rhinogrippal 200 mg / 30 mg is authorised by Swissmedic under authorisation number 68264, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Algifor Dolo Rhinogrippal 200 mg / 30 mg have?
Algifor Dolo Rhinogrippal 200 mg / 30 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Algifor Dolo Rhinogrippal 200 mg / 30 mg?
The authorisation holder is Verfora SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.